Source: Annual Congress 2003 - Clinical pathobiology in diffuse and in neoplastic disorders
Disease area: Interstitial lung diseases, Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
R. T. Stoica, R. Ulmeanu, A. Serbescu, A. Macri, S. Bliort (Bucharest, Romania). Results of twelve consecutive whole lung lavages in 5 cases of Alveolar Proteinosis. Eur Respir J 2003; 22: Suppl. 45, 1682

Member's Comments

No comment yet.

Related content which might interest you: Whole lung lavage (WLL) for patients with pulmonary alveolar proteinosis Source: Eur Respir J 2004; 24: Suppl. 48, 670s Year: 2004 BAL cytology in pulmonary alveolar proteinosis: a review of 7 cases Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008 Determinants of protein concentration in whole lung lavage of patients with pulmonary alveolar proteinosis Source: Annual Congress 2009 - From genetics to clinics in diffuse parenchymal lung diseases Year: 2009 The benefits of whole lung lavage in pulmonary alveolar proteinosis Source: Eur Respir J 2004; 23: 503-505 Year: 2004 Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis Source: Eur Respir J 2004; 23: 526-531 Year: 2004 Whole lung lavage (WLL) in pulmonary alveolar proteinosis (PAP): long-term lung function follow-up Source: Eur Respir J 2001; 18: Suppl. 33, 220s Year: 2001 Efficacy of total lung lavage in pulmonary alveolar proteinosis: A multicenter international study of GELF Source: International Congress 2016 – Advancements in bronchoscopy Year: 2016 KL-6 in whole lung lavage fluid of patients with pulmonary alveolar proteinosis Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease Year: 2009 Indication of whole lung lavage in pulmonary alveolar proteinosis – Retrospective study Source: International Congress 2015 – IIPs: orphan Year: 2015 Pulmonary alveolar proteinosis: failure of treatment by bronchoscopic lobar lavages and GM-CSF treatment in a child Source: Eur Respir J 2003; 22: Suppl. 45, 309s Year: 2003 Lung function and symptom improvement in patients with pulmonary alveolar proteinosis after whole lung lavage or N-acetylcysteine treatment Source: Eur Respir J 2005; 26: Suppl. 49, 83s Year: 2005 Multiple segmental lavage in the treatment of pulmonary alveolar proteinosis Source: International Congress 2014 – ILDs 6 Year: 2014 Mini-whole lung lavage to treat pulmonary alveolar proteinosis (PAP) Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 Whole lung lavage with intermittent double lung ventilation: a new technique for managing pulmonary alveolar proteinosis Source: Eur Respir J 2004; 24: Suppl. 48, 91s Year: 2004 Therapeutic whole-lung lavage in alveolar proteinosis Source: Annual Congress 2008 - Trends in interventional pulmonology Year: 2008 Long term follow up of the whole lung lavage programme in patients with pulmonary alveolar proteinosis: an update Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases Year: 2006 CD163 positive alveolar macrophages from bronchoalveolar lavage in idiopathic pulmonary fibrosis and lung cancer. Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019 Alveolar proteinosis: bronchopulmonary lavage - procedure and complications Source: Eur Respir J 2002; 20: Suppl. 38, 616s Year: 2002 Lung cysts in pulmonary alveolar proteinosis. Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018 Autophagy is not impaired in BALF alveolar macrophages in IPF: Preliminary results Source: International Congress 2014 – ILDs 3 Year: 2014